Healthcare provider profile · identity verified

Vibu Varghese, MD

Internal Medicine · FAIR LAWN, NJ · NPI 1316340979

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	107
Eliquis	Apixaban	340	50
Amlodipine Besylate	Amlodipine Besylate	307	64
Pantoprazole Sodium	Pantoprazole Sodium	274	80
Furosemide	Furosemide	203	47
Carvedilol	Carvedilol	184	30
Divalproex Sodium	Divalproex Sodium	181	31
Tamsulosin Hcl	Tamsulosin Hcl	181	45
Levothyroxine Sodium	Levothyroxine Sodium	179	37
Famotidine	Famotidine	164	28
Torsemide	Torsemide	164	19
Potassium Chloride	Potassium Chloride	143	18
Levetiracetam	Levetiracetam	142	22
Clopidogrel	Clopidogrel Bisulfate	138	35
Gabapentin	Gabapentin	135	34
Escitalopram Oxalate	Escitalopram Oxalate	131	28
Metformin Hcl	Metformin Hcl	129	25
Losartan Potassium	Losartan Potassium	123	27
Sertraline Hcl	Sertraline Hcl	123	14
Hydralazine Hcl	Hydralazine Hcl	119	28
Quetiapine Fumarate	Quetiapine Fumarate	118	27
Xarelto	Rivaroxaban	112	11
Metoprolol Succinate	Metoprolol Succinate	111	35
Omeprazole	Omeprazole	110	18
Lisinopril	Lisinopril	109	21
Mirtazapine	Mirtazapine	90	17
Simvastatin	Simvastatin	88	suppressed
Memantine Hcl	Memantine Hcl	87	19
Metoprolol Tartrate	Metoprolol Tartrate	84	23
Digoxin	Digoxin	82	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	20
Rosuvastatin Calcium	Rosuvastatin Calcium	78	suppressed
Alprazolam	Alprazolam	73	16
Baclofen	Baclofen	71	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	suppressed
Clonidine Hcl	Clonidine Hcl	69	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	66	20
Risperidone	Risperidone	64	suppressed
Finasteride	Finasteride	60	20
Sucralfate	Sucralfate	56	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	55	suppressed
Incruse Ellipta	Umeclidinium Bromide	52	suppressed
Donepezil Hcl	Donepezil Hcl	50	11
Ezetimibe	Ezetimibe	50	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Midodrine Hcl	Midodrine Hcl	48	13
Enoxaparin Sodium	Enoxaparin Sodium	47	12
Bupropion Hcl	Bupropion Hcl	46	suppressed
Montelukast Sodium	Montelukast Sodium	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	22
Sevelamer Carbonate	Sevelamer Carbonate	44	suppressed
Prednisone	Prednisone	41	14
Latanoprost	Latanoprost	38	11
Nystatin	Nystatin	38	23
Cephalexin	Cephalexin	36	25
Tramadol Hcl	Tramadol Hcl	36	19
Nifedipine Er	Nifedipine	35	suppressed
Albuterol Sulfate	Albuterol Sulfate	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Mupirocin	Mupirocin	33	13
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Entresto	Sacubitril/Valsartan	31	suppressed
Sodium Chloride	0.9 % Sodium Chloride	30	12
Budesonide	Budesonide	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	17
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Valsartan	Valsartan	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Aptiom	Eslicarbazepine Acetate	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Lactulose	Lactulose	27	17
Meloxicam	Meloxicam	26	11
Restasis	Cyclosporine	26	suppressed
Captopril-Hydrochlorothiazide	Captopril/Hydrochlorothiazide	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	13
Fluvoxamine Maleate	Fluvoxamine Maleate	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Lithium Carbonate	Lithium Carbonate	23	suppressed
Acetylcysteine	Acetylcysteine	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Calcitriol	Calcitriol	21	suppressed
Insulin Aspart Flexpen	Insulin Aspart	21	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Scopolamine	Scopolamine	21	suppressed
Folic Acid	Folic Acid	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	14
Phenytoin	Phenytoin	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	12
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	19	13
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Diazepam	Diazepam	18	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	18	suppressed
Meropenem	Meropenem	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Daptomycin	Daptomycin	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Nadolol	Nadolol	16	suppressed
Nystop	Nystatin	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Clonidine	Clonidine	14	suppressed
Kerendia	Finerenone	14	suppressed
Linzess	Linaclotide	14	suppressed
Miebo	Perfluorohexyloctane/Pf	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Valproic Acid	Valproic Acid	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Clomipramine Hcl	Clomipramine Hcl	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Modafinil	Modafinil	12	suppressed
Naproxen	Naproxen	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Rhopressa	Netarsudil Mesylate	11	suppressed
Risperidone Er	Risperidone Microspheres	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error